🌎 LDL-C Without Borders: A Global Call to Action

🌍 Why is the global LDL-C burden still rising despite decades of progress? The latest JAMA Global Burden of Disease 2023 analysis reveals a striking paradox: age-standardized cardiovascular risk attributable to LDL-C has fallen, yet absolute deaths and disability continue to increase because of population growth and aging. The message is clear—earlier detection, broader access to statins, and stronger preventive strategies remain essential, particularly in middle-income countries. 🫀📉